Robert W Duggan - Net Worth and Insider Trading

Robert W Duggan Net Worth

The estimated net worth of Robert W Duggan is at least $2.2 Billion dollars as of 2024-04-19. Robert W Duggan is the CEO of Summit Therapeutics Inc and owns about 552,354,161 shares of Summit Therapeutics Inc (SMMT) stock worth over $1.9 Billion. Robert W Duggan is the Director, 10% Owner of Pulse Biosciences Inc and owns about 37,827,813 shares of Pulse Biosciences Inc (PLSE) stock worth over $275 Million. Robert W Duggan is also the 10% Owner of Achaogen Inc and owns about 5,757,839 shares of Achaogen Inc (AKAOQ) stock worth over $143,946. Besides these, Robert W Duggan also holds Intuitive Surgical Inc (ISRG) . Details can be seen in Robert W Duggan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert W Duggan has not made any transactions after 2023-12-12 and currently still holds the listed stock(s).

Transaction Summary of Robert W Duggan

To

Robert W Duggan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert W Duggan owns 4 companies in total, including Summit Therapeutics Inc () , Pulse Biosciences Inc () , and Achaogen Inc () among others .

Click here to see the complete history of Robert W Duggan’s form 4 insider trades.

Insider Ownership Summary of Robert W Duggan

Ticker Comapny Transaction Date Type of Owner
Summit Therapeutics Inc 2023-03-06 director & 10 percent owner & See Remarks
Pulse Biosciences Inc 2023-12-12 director & 10 percent owner
Achaogen Inc 2019-03-20 10 percent owner
Intuitive Surgical Inc 2011-05-03 director

Robert W Duggan Latest Holdings Summary

Robert W Duggan currently owns a total of 4 stocks. Among these stocks, Robert W Duggan owns 552,354,161 shares of Summit Therapeutics Inc (SMMT) as of March 6, 2023, with a value of $1.9 Billion and a weighting of 87.48%. Robert W Duggan owns 37,827,813 shares of Pulse Biosciences Inc (PLSE) as of December 12, 2023, with a value of $275 Million and a weighting of 12.51%. Robert W Duggan also owns 5,757,839 shares of Achaogen Inc (AKAOQ) as of March 20, 2019, with a value of $143,946 and a weighting of 0.01%. The other 1 stocks Intuitive Surgical Inc (ISRG) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Robert W Duggan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SMMT Summit Therapeutics Inc 2023-03-06 552,354,161 3.48 1,922,192,480
PLSE Pulse Biosciences Inc 2023-12-12 37,827,813 7.27 274,834,193
AKAOQ Achaogen Inc 2019-03-20 5,757,839 0.03 143,946
ISRG Intuitive Surgical Inc 2011-05-03 0 375.00 0

Holding Weightings of Robert W Duggan


Robert W Duggan Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert W Duggan has made a total of 3 transactions in Summit Therapeutics Inc (SMMT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Summit Therapeutics Inc is the acquisition of 376,489,880 shares on March 6, 2023, which cost Robert W Duggan around $395 Million.

According to the SEC Form 4 filings, Robert W Duggan has made a total of 13 transactions in Pulse Biosciences Inc (PLSE) over the past 5 years, including 13 buys and 0 sells. The most-recent trade in Pulse Biosciences Inc is the acquisition of 17,999 shares on December 12, 2023, which cost Robert W Duggan around $164,691.

According to the SEC Form 4 filings, Robert W Duggan has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the sale of 1,277,888 shares on March 20, 2019, which brought Robert W Duggan around $690,060.

More details on Robert W Duggan's insider transactions can be found in the Insider Trading History of Robert W Duggan table.

Insider Trading History of Robert W Duggan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert W Duggan Trading Performance

GuruFocus tracks the stock performance after each of Robert W Duggan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert W Duggan is 6.83%. GuruFocus also compares Robert W Duggan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert W Duggan within 3 months outperforms 23 times out of 47 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert W Duggan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert W Duggan

Average Return

-43.3%

Average return per transaction

Outperforming Transactions

12%

4 out of 34 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.67 6.83 -24.16 -43.3 -57.44 -48.05
Relative Return to S&P 500(%) 10.76 1.01 -30.68 -54.18 -65.06 -58.85

Robert W Duggan Ownership Network

Ownership Network List of Robert W Duggan

No Data

Ownership Network Relation of Robert W Duggan


Robert W Duggan Owned Company Details

What does Summit Therapeutics Inc do?

Who are the key executives at Summit Therapeutics Inc?

Robert W Duggan is the director & 10 percent owner & See Remarks of Summit Therapeutics Inc. Other key executives at Summit Therapeutics Inc include Chief Financial Officer Ankur Dhingra , VP & Corporate Controller Jeffrey R Maranian , and Chief Scientific Officer David Jonathan Powell .

Summit Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Robert W Duggan made 1 insider transaction in Summit Therapeutics Inc () with a net purchase of 376,489,880. Other recent insider transactions involving Summit Therapeutics Inc () include a net purchase of 47,169,409 shares made by Maky Zanganeh , a net purchase of 316,762 shares made by Ankur Dhingra , and a net purchase of 2,976,190 shares made by Manmeet Singh Soni .

In summary, during the past 3 months, insiders sold 0 shares of Summit Therapeutics Inc () in total and bought 210,321 shares, with a net purchase of 210,321 shares. During the past 18 months, 0 shares of Summit Therapeutics Inc () were sold and 426,952,241 shares were bought by its insiders, resulting in a net purchase of 426,952,241 shares.

Summit Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Summit Therapeutics Inc Insider Transactions

No Available Data

Robert W Duggan Mailing Address

Above is the net worth, insider trading, and ownership report for Robert W Duggan. You might contact Robert W Duggan via mailing address: 611 South Fort Harrison Ave, Suite 306, Clearwater Fl 33756.

Discussions on Robert W Duggan

No discussions yet.